Sandoz Spin-Off Planned For 4 October 2023

Aug 18, 2023

Novartis issued an invitation to an Extraordinary General Meeting (EGM) of Novartis shareholders scheduled for 15 September 2023 to vote on the approach to the proposed spin-off of Sandoz, which includes the planned spin-off effective date of 4 October 2023.

On 18 July 2023, Novartis’ board unanimously endorsed a Q4/23 Sandoz spin-off.

Print Page Mail Article